Reports

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Psoriatic Arthritis Treatment Market: By Drug Class: NSAIDs, DMARDs, Biologics, Other; By Product Type: Prescription, OTC; By Route of Administration: Topical, Oral, Injectable; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; SWOT Analysis; Competitive Landscape; Industry Events and Developments

Global Psoriatic Arthritis Treatment Market Outlook

The global psoriatic arthritis treatment market attained a value at USD 8.4 billion in 2020 and is further expected to grow at a CAGR of 9.8% over the forecast period of 2021-2026.

 

Global Psoriatic Arthritis Treatment Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

It is estimated that psoriasis affects more than 125 million individuals around the globe, and psoriasis tends to create psoriatic arthritis in 30% of the population. The global industry for psoriatic arthritis treatment is influenced by an increasing acceptance of medical therapy by patients suffering from moderate to serious psoriatic arthritis.

 

Properties and Applications

Psoriatic arthritis is a chronic psoriasis-related degenerative disorder. Swollen fingers, toes, and tender joints, stiffness, lowered back pain, and pitted nails are prevalent symptoms of psoriatic arthritis. Psoriatic arthritis treatment market can be divided on the basis of segments like drug class, product type and administration route.

 

Global Psoriatic Arthritis Treatment Market By Drug Class

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF


On the basis of its drug class, the market can be widely categorised as:

  • NSAIDs 
  • DMARDs
  • Biologics 
  • Other

Based on its product type, the market can be bifurcated as prescription and OTC.

The different administration route available for psoriatic arthritis treatment are topical, oral and injectable.

The EMR report looks into the regional psoriatic arthritis treatment markets like the North America, Latin America, Europe, Middle East and Africa, and Asia Pacific.

 

Global Psoriatic Arthritis Treatment Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

The intensive research taking place to provide treatment to the patients suffering from psoriasis condition is driving the global psoriatic arthritis treatment industry. The other factors aiding in the growth of the industry are investments by major companies in clinical R&D, new product launches, increasing disease prevalence and proactive government initiatives. The factors such as high cost of treatment, stringent regulatory approval and adverse effect of drugs may hinder the growth of the market in coming future.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global psoriatic arthritis treatment industry, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • AbbVie Inc. 
  • Amgen, Inc.
  • Johnson & Johnson Services, Inc.
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • Novartis International AG
  • Eli Lilly and Company
  • Pfizer, Inc.
  • UCB S.A                    
  • AstraZeneca plc
  • Others

The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s five forces.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2016-2020
Forecast Period 2021-2026
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Drug Class, Product Type, Route of Administration, Region
Breakup by Drug Class NSAIDs, DMARDs, Biologics, Other
Breakup by Product Type Prescription, OTC
Breakup by Administration Topical, Oral, Injectable
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered AbbVie Inc., Amgen, Inc., Johnson & Johnson Services, Inc., Bristol-Myers Squibb Company, Celgene Corporation, Novartis International AG, Eli Lilly and Company, Pfizer, Inc., UCB S.A, AstraZeneca plc, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key findings of the Study
2    Research Methodology
    2.1    Data Extraction
    2.2    Data Corroboration
    2.3    Market Structure
    2.4    Inference Data
3    Executive Summary
    3.1    Market Overview
    3.2    Market Analysis 
4    Global Psoriatic Arthritis Treatment Market 
    4.1    Global Psoriatic Arthritis Market (2016-2020) & Forecast (2021-2026)
    4.2    Global Psoriatic Arthritis Treatment Market Breakup by Drug Class
        4.2.1    NSAIDs 
        4.2.2    DMARDs
        4.2.3    Biologics 
        4.2.4    Other
    4.3    Global Psoriatic Arthritis Treatment Market Breakup by Drug Class: Historical Market (2016-2020) & Forecast (2021-2026)
        4.3.1    NSAIDs 
        4.3.2    DMARDs
        4.3.3    Biologics 
        4.3.4    Other
    4.4    Global Psoriatic Arthritis Treatment Market Breakup by Product Type
        4.4.1    Prescription
        4.4.2    OTC
    4.5    Global Psoriatic Arthritis Treatment Market Breakup by Product Type: Historical Market (2016-2020) & Forecast (2021-2026)
        4.5.1    Prescription
        4.5.2    OTC
    4.6    Global Psoriatic Arthritis Treatment Market Breakup by Route of Administration
        4.6.1    Topical
        4.6.2    Oral
        4.6.3    Injectable
    4.7    Global Psoriatic Arthritis Treatment Market Breakup by Route of Administration: Historical Market (2016-2020) & Forecast (2021-2026)
        4.7.1    Topical
        4.7.2    Oral
        4.7.3    Injectable
    4.8    Global Psoriatic Arthritis Treatment Market Breakup by Region
        4.8.1    North America
            4.8.1.1    United States of America
            4.8.1.2    Canada
        4.8.2    Europe
            4.8.2.1    Germany
            4.8.2.2    United Kingdom
            4.8.2.3    France
            4.8.2.4    Italy
            4.8.2.5    Others
        4.8.3    Asia Pacific
            4.8.3.1    China
            4.8.3.2    Japan
            4.8.3.3    India
            4.8.3.4    ASEAN
            4.8.3.5    Others
        4.8.4    Latin America
            4.8.4.1    Brazil
            4.8.4.2    Argentina
            4.8.4.3    Mexico
            4.8.4.4    Others
        4.8.5    Middle East & Africa
            4.8.5.1    Saudi Arabia
            4.8.5.2    United Arab Emirates
            4.8.5.3    Nigeria
            4.8.5.4    South Africa
            4.8.5.5    Others
    4.9     Global Psoriatic Arthritis Treatment Market Breakup by Region: Historical Market (2016-2020) & Forecast (2021-2026)
        4.9.1    North America
            4.9.1.1    United States of America
            4.9.1.2    Canada
        4.9.2    Europe
            4.9.2.1    Germany
            4.9.2.2    United Kingdom
            4.9.2.3    France
            4.9.2.4    Italy
            4.9.2.5    Others
        4.9.3    Asia Pacific
            4.9.3.1    China
            4.9.3.2    Japan
            4.9.3.3    India
            4.9.3.4    ASEAN
            4.9.3.5    Others
        4.9.4    Latin America
            4.9.4.1    Brazil
            4.9.4.2    Argentina
            4.9.4.3    Mexico
            4.9.4.4    Others
        4.9.5    Middle East & Africa
            4.9.5.1    Saudi Arabia
            4.9.5.2    United Arab Emirates
            4.9.5.3    Nigeria
            4.9.5.4    South Africa
            4.9.5.5    Others
5    SWOT Analysis
    5.1    Overview
    5.2    Strengths
    5.3    Weaknesses
    5.4    Opportunities
    5.5    Threats
6    Porter’s Five Forces Analysis
    6.1    Overview
    6.2    Buyer’s Power
    6.3    Supplier’s Power
    6.4    New Entrants
    6.5    Degree of Rivalry
    6.6    Substitutes
7    Key Players & Company Profile Analysis 
    7.1    AbbVie Inc. 
    7.2    Amgen, Inc.
    7.3    Johnson & Johnson Services, Inc.
    7.4    Bristol-Myers Squibb Company
    7.5    Celgene Corporation
    7.6    Novartis International AG
    7.7    Eli Lilly and Company
    7.8    Pfizer, Inc.
    7.9    UCB S.A                    
    7.10    AstraZeneca plc
    7.11    Others
8    Industry Events and Developments

Key Questions Answered in the Report

In 2020, the global psoriatic arthritis treatment market attained a value of nearly USD 8.4 billion.

The market is projected to grow at a CAGR of 9.8% between 2021 and 2026.

The major drivers of the market include the increasing acceptance of medical therapy by patients suffering from moderate to serious psoriatic arthritis, new product launches, growing disease prevalence, and rising government initiatives.

The intensive research taking place to provide treatment to the patients suffering from psoriasis condition is the key industry trend propelling the growth of the market.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The leading drug classes of psoriatic arthritis treatment in the industry are NSAIDs, DMARDs, and biologics, among others.

The significant product types in the market are prescription and OTC.

The major routes of administration of psoriatic arthritis treatment in the industry are topical, oral, and injectable.

The major players in the industry are AbbVie Inc., Amgen Inc., Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Celgene Corporation, Novartis International AG, Eli Lilly and Company, Pfizer Inc., UCB SA, and AstraZeneca plc, among others.

Analyst Review

The global psoriatic arthritis treatment market attained a value of USD 8.4 billion in 2020, driven by the increasing acceptance of medical therapy by patients. Aided by the growing R&D activities, the market is expected to witness a further growth in the forecast period of 2021-2026, growing at a CAGR of 9.8%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on drug class, the psoriatic arthritis treatment industry can be segmented into NSAIDs, DMARDs, biologics, and other. On the basis of product type, the psoriatic arthritis treatment market is divided into prescription, and OTC. The psoriatic arthritis treatment industry can be segregated based on administration route into topical, oral, and injectable. The major regional markets for psoriatic arthritis treatment are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include AbbVie Inc., Amgen Inc., Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Celgene Corporation, Novartis International AG, Eli Lilly and Company, Pfizer Inc., UCB SA, AstraZeneca plc, and others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER